A design of phase II cancer trials using total and complete response endpoints
- 27 September 2005
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 24 (20) , 3155-3170
- https://doi.org/10.1002/sim.2188
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- An optimal two-stage phase II design utilizing complete and partial response information separatelyControlled Clinical Trials, 2002
- Intravenous Immunoglobulin for Hemophagocytic Lymphohistiocytosis?Journal of Clinical Oncology, 2002
- Graphical Search for Two-Stage Designs for Phase II Clinical TrialsControlled Clinical Trials, 2001
- Application of a New Multinomial Phase II Stopping Rule Using Response and Early ProgressionJournal of Clinical Oncology, 2001
- Optimal two-stage designs for phase ii clinical trials with differentiation of complete and partial responsesCommunications in Statistics - Theory and Methods, 2000
- MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSIONJournal of Biopharmaceutical Statistics, 1999
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agentJournal of Chronic Diseases, 1961